KG Co Gmbh Ventures Medical Tvm Net Worth & Insider Trades

KG Co Gmbh Ventures Medical Tvm Enanta Pharmaceuticals Inc

As of March 5, 2014

What is KG Co Gmbh Ventures Medical Tvm's Net Worth?

The current estimated net worth of Enanta Pharmaceuticals Inc's KG Co Gmbh Ventures Medical Tvm is estimated to be about $79.07M . KG Co Gmbh Ventures Medical Tvm owns about 1,178,534 units of Enanta Pharmaceuticals Inc common stock. In the last year at Enanta Pharmaceuticals Inc, KG Co Gmbh Ventures Medical Tvm has sold an estimated value of $28.86M worth.

What is KG Co Gmbh Ventures Medical Tvm's Past Insider Trading?

KG Co Gmbh Ventures Medical Tvm's largest purchase order was 2,532,119 units , worth over $1.86M on March 28, 2013. KG Co Gmbh Ventures Medical Tvm's largest sale order was 439,334 units , worth over $17.05M on March 5, 2014. In total, KG Co Gmbh Ventures Medical Tvm has made about 5 transactions over a year of their time at Enanta Pharmaceuticals Inc. KG Co Gmbh Ventures Medical Tvm usually trades in February, with the busiest year in 2014.

KG CO GMBH VENTURES SCIENCE LIFE TVM V, KG Co GmbH Management Ventures Science Life TVM V, KG CO GMBH TVM IV, KG Co GmbH Management TVM IV, KG CO GMBH VENTURES MEDICAL TVM, GmbH Capital TVM, Hubert Birner, Stefan Fischer, Alexandra Goll, HELMUT SCHUHSLER

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is KG Co Gmbh Ventures Medical Tvm's' Mailing Address?

  • Mailing address is C/o Tvm Techno Venture Management Maximillianstr. 35, Entrance C D-80539 Munich 2M 80539 Germany

What are Enanta Pharmaceuticals Inc's Past Insider Trades?

Enanta Pharmaceuticals Inc's most recent insider trade came on April 5, 2022 by Nathalie Adda who sold 83,344 units worth $5.97M . In the last 9 years, insiders at Enanta Pharmaceuticals Inc have sold an estimated value of $97.83M and bought an estimated value of $18.01M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Paul Mellett, Treasurer and CFO,  Jay Luly, President and CEO,  and Nathaniel S. Gardiner As Attorney-In-Fact, Sr. VP & CSO .

ENANTA PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1